Risk of adverse fetal outcomes following administration of a pandemic influenza A(H1N1) vaccine during pregnancy

JAMA

Volumn 308, Issue 2, 2012, Pages 165-174

  Pasternak, Björn ^a   Svanstrom̈, Henrik ^a   Mølgaard Nielsen, Ditte ^a   Krause, Tyra G ^a   Emborg, Hanne Dorthe ^a   Melbye, Mads ^a   Hviid, Anders ^a  

^a STATENS SERUM INSTITUT   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE;

ADULT; ARTICLE; BIRTH DEFECT; BIRTH WEIGHT; BODY MASS; COMORBIDITY; CONTROLLED STUDY; DIABETES MELLITUS; ENVIRONMENTAL EXPOSURE; FETUS OUTCOME; FIRST TRIMESTER PREGNANCY; GESTATIONAL AGE; HEALTH CARE UTILIZATION; HUMAN; INFANT; INTRAUTERINE GROWTH RETARDATION; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; PANDEMIC INFLUENZA; PARITY; PREGNANCY; PREGNANCY OUTCOME; PREMATURE LABOR; PREVALENCE; PRIORITY JOURNAL; RESPIRATORY TRACT DISEASE; RISK ASSESSMENT; SECOND TRIMESTER PREGNANCY; SENSITIVITY ANALYSIS; SMOKING; THIRD TRIMESTER PREGNANCY; VACCINATION;

EID: 84863707296     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2012.6131     Document Type: Article

References (35)

1. Louie JK, Acosta M, Jamieson DJ, Honein MA; California Pandemic (H1N1) Working Group. Severe 2009 H1N1 influenza in pregnant and postpartum women in California. N Engl J Med. 2010;362 (1):27-35.
2. Mosby LG, Rasmussen SA, Jamieson DJ. 2009 pandemic influenza A (H1N1) in pregnancy. Am J Obstet Gynecol. 2011;205(1):10-18.
3. Siston AM, Rasmussen SA, Honein MA, et al; Pandemic H1N1 Influenza in Pregnancy Working Group. Pandemic 2009 influenza A(H1N1) virus illness among pregnant women in the United States. JAMA. 2010; 303(15):1517-1525.
4. Pierce M, Kurinczuk JJ, Spark P, Brocklehurst P, Knight M; UKOSS. Perinatal outcomes after maternal 2009/H1N1 infection. BMJ. 2011;342:d3214.
5. National Center for Immunization and Respiratory Diseases; Centers for Disease Control and Prevention. Use of influenza A (H1N1) 2009 monovalent vaccine. MMWR Recomm Rep. 2009; 58(RR-10):1-8.
6. Moro PL, Broder K, Zheteyeva Y, et al. Adverse events following administration to pregnant women of influenza A (H1N1) 2009 monovalent vaccine reported to the Vaccine Adverse Event Reporting System. Am J Obstet Gynecol. 2011;205(5):473-479, e1-e9.
7. European Medicines Agency. Eleventh pandemic pharmacovigilance weekly update. http://www.ema.europa.eu/docs/en-GB/document-library/Report/2010/02/ WC500073992.pdf. Accessed November 28, 2011.
8. European Medicines Agency. Twenty-second pandemic pharmacovigilance update. http://www.ema.europa.eu/docs/en-GB/document-library/Report/2010/08/ WC500095870.pdf. Accessed November 28, 2011.
9. Huang WT, Chen WC, Teng HJ, et al. Adverse events following pandemic A (H1N1) 2009 monovalent vaccines in pregnant women-Taiwan, November 2009-August 2010. PLoS One. 2011;6(8): e23049.
10. Lacroix I, Damase-Michel C, Kreft-Jais C, Castot A, Montastruc JL; French Association of Regional Pharmacovigilance Centres. 2009 H1N1 influenza vaccines in pregnant women: the French Pharmacovigilance survey. Vaccine. 2011;29(7):1357-1358.
11. Tavares F, Nazareth I, Monegal JS, Kolte I, Verstraeten T, Bauchau V. Pregnancy and safety outcomes in women vaccinated with an AS03-adjuvanted split virion H1N1 (2009) pandemic influenza vaccine during pregnancy: a prospective cohort study. Vaccine. 2011;29(37):6358-6365.
12. Omon E, Damase-Michel C, Hurault-Delarue C, et al. Non-adjuvanted 2009 influenza A (H1N1)v vaccine in pregnant women. Vaccine. 2011;29(52): 9649-9654.
13. Mackenzie IS, MacDonald TM, Shakir S, et al. Influenza H1N1 (swine flu) vaccination. Br J Clin Pharmacol. 2012;73(5):801-811.
14. Tsatsaris V, Capitant C, Schmitz T, et al; Inserm C09-33 PREFLUVAC (Immunogenicity and Safety of an Inactivated Nonadjuvanted A[H1N1v] Influenza Vaccine in Pregnant Women) Study Group. Maternal immune response and neonatal seroprotection from a single dose of a monovalent nonadjuvanted 2009 influenza A(H1N1) vaccine: a single-group trial. Ann Intern Med. 2011;155(11):733-741.
15. Pedersen CB, Gøtzsche H, Møller JO, Mortensen PB. The Danish Civil Registration System. Dan Med Bull. 2006;53(4):441-449.
16. Knudsen LB, Olsen J. The Danish Medical Birth Registry. Dan Med Bull. 1998;45(3):320-323. (Pubitemid 28313542)
17. Jørgensen FS. Ultrasonography of pregnant women in Denmark 1999-2000: description of the development since 1980-1990. Ugeskr Laeger. 2003; 165(46):4409-4415. (Pubitemid 38113469)
18. Pasternak B, Hviid A. Use of acyclovir, valacyclovir, and famciclovir in the first trimester of pregnancy and the risk of birth defects. JAMA. 2010;304 (8):859-866.
19. Folkenberg M, Callréus T, Svanström H, Valentiner-Branth P, Hviid A. Spontaneous reporting of adverse events following immunisation against pandemic influenza in Denmark November 2009-March 2010. Vaccine. 2011;29(6):1180-1184.
20. Danish National Board of Health. Recommendations for vaccination of persons at risk of severe disease because of A(H1N1)v infection [In Danish]. http://www.sst.dk/~/media/Sundhed%20og%20forebyggelse/Smitsomme%20sygdomme/ Influenza/Vaccination-lister/Anbefalinger-vaccination-risikogrupper23okt.ashx. October 2009. Accessed November 25, 2011.
21. Andersen TF, Madsen M, Jørgensen J, Mellemkjoer L, Olsen JH. The Danish National Hospital Register: a valuable source of data for modern health sciences. Dan Med Bull. 1999;46(3):263-268. (Pubitemid 29299976)
22. EUROCAT Central Registry. Eurocat guide 1.3 and reference documents, instructions for the registration and surveillance of congenital anomalies, chapter 3.3: coding of Eurocat subgroups of congenital anomalies, issued on 01-03-2007. http://www.eurocat-network.eu/content/EUROCAT-Guide-1.3.pdf. Accessed November 23, 2011.
23. EUROCAT Central Registry. Prevalence tables. http://www.eurocat-network. eu/accessprevalencedata/prevalencetables. Accessed April 17, 2012.
24. Kildemoes HW, Sørensen HT, Hallas J. The Danish National Prescription Registry. Scand J Public Health. 2011;39(7)(suppl):38-41.
25. Clayton D, Hills M. Poisson and logistic regression. In: Clayton D, Hills M, eds. Statistical Models in Epidemiology. Oxford, England: Oxford University Press; 1993:227-236.
26. Buhimschi CS, Weiner CP. Medications in pregnancy and lactation: part 1: teratology. Obstet Gynecol. 2009;113(1):166-188.
27. Pasternak B, Svanström H, Mølgaard-Nielsen D, et al. Vaccination against pandemic A(H1N1) 2009 influenza in pregnancy and risk of fetal death: cohort study in Denmark. BMJ. 2012;344:e2794.
28. Mak TK, Mangtani P, Leese J, Watson JM, Pfeifer D. Influenza vaccination in pregnancy. Lancet Infect Dis. 2008;8(1):44-52.
29. Tamma PD, Ault KA, del Rio C, Steinhoff MC, Halsey NA, Omer SB. Safety of influenza vaccination during pregnancy. Am J Obstet Gynecol. 2009; 201(6):547-552.
30. Lambert LC, Fauci AS. Influenza vaccines for the future. N Engl J Med. 2010;363(21):2036-2044.
31. Boyd HA, Poulsen G, Wohlfahrt J, Murray JC, Feenstra B, Melbye M. Maternal contributions to preterm delivery. Am J Epidemiol. 2009;170(11):1358- 1364.
32. Centers for Disease Control and Prevention (CDC). Influenza vaccination coverage among pregnant women - 29 states and New York City, 2009-10 season. MMWR Morb Mortal Wkly Rep. 2012; 61(7):113-118.
33. Bone A, Guthmann JP, Nicolau J, Lévy-Bruhl D. Population and risk group uptake of H1N1 influenza vaccine in mainland France 2009-2010. Vaccine. 2010; 28(51):8157-8161.
34. Walter D, Böhmer MM, Heiden M, Reiter S, Krause G, Wichmann O. Monitoring pandemic influenza A(H1N1) vaccination coverage in Germany 2009/10 - results from thirteen consecutive cross-sectional surveys. Vaccine. 2011;29(23): 4008-4012.
35. Skowronski DM, De Serres G. Is routine influenza immunization warranted in early pregnancy? Vaccine. 2009;27(35):4754-4770.